Catherine Dubos Arvis
- Oncology top 0.2%
- Pulmonary and Respiratory Medicine top 0.5%
- Immunology top 2%
- Cancer Research top 5%
- Molecular Biology
- Co-authors
- Paul BaasGregory M. LubinieckiEdward B. GaronRoy S. HerbstMargarita MajemJi‐Youn HanJosé Luis Perez‐GraciaEnriqueta Felip
- Topics
- Cancer Immunotherapy and Biomarkers (11 papers)Lung Cancer Treatments and Mutations (7 papers)Colorectal Cancer Treatments and Studies (6 papers)
- Partner nations
- FranceSpainSouth Korea
In The Last Decade
Catherine Dubos Arvis
16 papers receiving 5.2k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Oncology 4.8k
- Pulmonary and Respiratory Medicine 3.2k
- Immunology 1.0k
- Cancer Research 585
- Molecular Biology 444
Countries citing papers authored by Catherine Dubos Arvis
This map shows the geographic impact of Catherine Dubos Arvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Dubos Arvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Dubos Arvis more than expected).
Fields of papers citing papers by Catherine Dubos Arvis
This network shows the impact of papers produced by Catherine Dubos Arvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Dubos Arvis. The network helps show where Catherine Dubos Arvis may publish in the future.
Co-authorship network of co-authors of Catherine Dubos Arvis
This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Dubos Arvis. A scholar is included among the top collaborators of Catherine Dubos Arvis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Dubos Arvis. Catherine Dubos Arvis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 201 | |
| 2 | 31 | |
| 3 | 46 | |
| 4 | 17 | |
| 5 | 22 | |
| 6 | 16 | |
| 7 | 23 | |
| 8 | 7 | |
| 9 | 2 | |
| 10 | 6 | |
| 11 | 1 | |
| 12 | 11 | |
| 13 | 11 | |
| 14 | 4 | |
| 15 | 12 | |
| 16 | Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trialbreakdown → | 4873 |
About Catherine Dubos Arvis
Catherine Dubos Arvis is a scholar working on Oncology, Process Chemistry and Technology and Cancer Research, having authored 16 papers that have together received 5.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Lung Cancer Treatments and Mutations (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (4.8k citations), Pulmonary and Respiratory Medicine (3.2k citations) and Immunology (1.0k citations). Catherine Dubos Arvis has collaborated with scholars based in France, Spain and South Korea. Frequent co-authors include Paul Baas, Gregory M. Lubiniecki, Edward B. Garon, Roy S. Herbst, Margarita Majem, Ji‐Youn Han, José Luis Perez‐Gracia, Enriqueta Felip, Mary J. Fidler and Dong‐Wan Kim. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.